Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-039035

Chief Medical Officer sold 4,000 shares at an average $33.60 ($134,387)

  • Chief Medical Officer acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Alland Leila · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-07 Exercise or conversion : show line 1 in the form +4,000 $3.90 $15,600 4,000 D
2021-06-07 Sale : show line 2 in the form −2,633 $33.39 $87,903 1,367 D
2021-06-07 Sale : show line 3 in the form −1,367 $34.00 $46,484 0 D
Open-market sales · 4,000 sh · avg $33.60 · $134,387

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-05-12 Grant or award : show line 4 in the form Employee Stock Option (right to buy) +36,279 36,279 D
2021-06-07 Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) −4,000 365,850 D
Loading xslF345X03/doc4.xml…